UBUYOBOZI

AI muri Pathology

Computational pathology applies image-analysis methods to digitized tissue slides.

Umva iki gitaboAI-byavuzwe · ~1 min

Kuriyi page1 min soma
  1. Incamake
  2. Kwibira cyane
  3. Gushyira mu bikorwa Isi
  4. Kazoza ka AI muri Pathology
  5. Kubishyira mubikorwa
  6. Komeza Ubushakashatsi
  7. Ibibazo bikunze kubazwa

Incamake

Whole-slide images are large, so models often process patches and combine patch-level evidence for slide-level tasks.

Kwibira cyane

The FDA De Novo review for Paige Prostate describes a computer-assisted pathology device that identifies suspicious areas on digitized prostate biopsy slides for pathologist review. CLAM is a research approach using attention-based multiple-instance learning for whole-slide classification with slide-level labels. Ki-67 is a cell-proliferation marker discussed in oncology. These tools and markers address specific tasks; their research or regulatory status does not generalize to every tissue, cancer or clinical decision.

Gushyira mu bikorwa Isi

A whole-slide image can be divided into tiles for model processing.

Multiple-instance learning can learn from slide-level labels when every patch is not individually annotated.

The FDA-reviewed Paige Prostate device assists pathologists with a specific prostate-biopsy review task.

Ki-67 is a protein marker used in assessing cell proliferation; an AI count is a measurement aid, not a standalone cancer diagnosis.

Kazoza ka AI muri Pathology

Report the tissue type, scanner, population, reference standard and intended use when evaluating pathology AI. Keep pathologist oversight and assess performance across sites and specimen types. A clearance or benchmark for one device does not establish general clinical utility across pathology.

Kubishyira mubikorwa

Impamvu ari ngombwa

  • Imirongo n'amategeko. Inganda zerekana niba ibitekerezo bya AI bikomeza guhura nukuri.
  • Kugenzura ubuziranenge. Imbogamizi za domeni zigira ingaruka zemewe namakosa yo kugenzura.
  • Kubaka amahitamo. Ibikorwa bigenda neza bihuza ubushobozi bwa tekiniki hamwe nakazi kambere.

Witondere

  • Ibisabwa kugenzurwa birashobora gutesha agaciro ubundi prototypes ikomeye.
  • Amakuru yamateka arashobora gushiramo kubogama byangiza abaturage.
  • Sisitemu yumurage irashobora gushiraho uburyo bwo kwishyira hamwe nibiciro byihishe.

Intambwe ikurikira

  1. Shyiramo abahanga ba domaine kuva ibibazo bitegura gusuzuma.
  2. Shushanya inzira y'ubugenzuzi n'inyandiko mbere yo gutangira.
  3. Emeza kubahiriza inshingano z'umutekano hakiri kare.
  4. Kuzenguruka mu byiciro hamwe no guhagarara neza no kugaruka.

Komeza Ubushakashatsi

Ibaruwa y'amakuru y'ubuntu

Ibuka amakuru ya buri munsi ya AI

Inkuru eshatu zizewe za AI buri gitondo cy'iminsi y'akazi, zanditse mu rurimi rworoshye. Ubuntu iteka ryose, nta kwamamaza.

Imeri imwe buri munsi y'akazi. Kwiyimura mu buryo bumwe. Ntitwigera tugurisha cyangwa ngo dusangire aderesi yawe.

Isuzume

Take the AI in Pathology quiz

Ibisubizo ako kanya kuri buri kibazo, n'icyemezo gishobora gusangirwa gifite ID yagenzurwa umaze gutsinda isomo.

Tangira ikibazo

Fasha uburezi bwa AI bw'ubuntu. AI Understanding ni umuryango utegamiye kuri leta wa 501(c)(3) — nta kwamamaza, nta kwishyura, iteka ryose. Tanga impano

Ibibazo bikunze kubazwa

What is AI in Pathology?

Computational pathology applies image-analysis methods to digitized tissue slides. Whole-slide images are large, so models often process patches and combine patch-level evidence for slide-level tasks.

Niki 'ishusho-yuzuye ishusho' muburyo bwa digitologiya?

Amashusho asikanwa mumashusho manini ya gigapixel, akenshi miriyari ya pigiseli, AI noneho isesengura.

Kuki moderi ya AI itunganya amashusho mumashusho mato cyangwa uduce?

Amashusho yose-yerekana amashusho ni manini cyane kugirango yinjizwemo icyitegererezo, bityo agabanyijemo amatafari ibihumbi n'ibisubizo hamwe.

What regulatory pathway did FDA use for Paige Prostate?

FDA’s DEN200080 record is a De Novo classification for a specific software device and intended use; the decision does not generalize to all pathology AI.

Ni iki AI Ki-67 ibara mu kibyimba?

Ki-67 ni ikimenyetso cyo gukwirakwiza selile, kandi kubara ingirabuzimafatizo nziza byerekana uburyo ikibyimba gikura.

What can an AI system provide in a pathology workflow, according to the scoped examples?

The cited FDA review describes a device intended to assist pathologists; its output is not a standalone diagnosis or treatment decision.